BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 29973231)

  • 1. The inhibitory effect of LPS on the expression of GPR81 lactate receptor in blood-brain barrier model in vitro.
    Boitsova EB; Morgun AV; Osipova ED; Pozhilenkova EA; Martinova GP; Frolova OV; Olovannikova RY; Tohidpour A; Gorina YV; Panina YA; Salmina AB
    J Neuroinflammation; 2018 Jul; 15(1):196. PubMed ID: 29973231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poldip2 mediates blood-brain barrier disruption in a model of sepsis-associated encephalopathy.
    Kikuchi DS; Campos ACP; Qu H; Forrester SJ; Pagano RL; Lassègue B; Sadikot RT; Griendling KK; Hernandes MS
    J Neuroinflammation; 2019 Nov; 16(1):241. PubMed ID: 31779628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-1β induces an inflammatory response and the breakdown of the endothelial cell layer in an improved human THBMEC-based in vitro blood-brain barrier model.
    Labus J; Häckel S; Lucka L; Danker K
    J Neurosci Methods; 2014 May; 228():35-45. PubMed ID: 24631939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit.
    Banks WA; Gray AM; Erickson MA; Salameh TS; Damodarasamy M; Sheibani N; Meabon JS; Wing EE; Morofuji Y; Cook DG; Reed MJ
    J Neuroinflammation; 2015 Nov; 12():223. PubMed ID: 26608623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ramelteon Ameliorates LPS-Induced Hyperpermeability of the Blood-Brain Barrier (BBB) by Activating Nrf2.
    Liu Y; Wang L; Du N; Yin X; Shao H; Yang L
    Inflammation; 2021 Oct; 44(5):1750-1761. PubMed ID: 33876343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fructose-1,6-bisphosphate ameliorates lipopolysaccharide-induced dysfunction of blood-brain barrier.
    Seok SM; Kim JM; Park TY; Baik EJ; Lee SH
    Arch Pharm Res; 2013 Sep; 36(9):1149-59. PubMed ID: 23604722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure to vehicle emissions results in altered blood brain barrier permeability and expression of matrix metalloproteinases and tight junction proteins in mice.
    Oppenheim HA; Lucero J; Guyot AC; Herbert LM; McDonald JD; Mabondzo A; Lund AK
    Part Fibre Toxicol; 2013 Dec; 10():62. PubMed ID: 24344990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cells stabilize the blood-brain barrier through regulation of astrocytes.
    Park HJ; Shin JY; Kim HN; Oh SH; Song SK; Lee PH
    Stem Cell Res Ther; 2015 Sep; 6():187. PubMed ID: 26420371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial dysfunction mediated through dynamin-related protein 1 (Drp1) propagates impairment in blood brain barrier in septic encephalopathy.
    Haileselassie B; Joshi AU; Minhas PS; Mukherjee R; Andreasson KI; Mochly-Rosen D
    J Neuroinflammation; 2020 Jan; 17(1):36. PubMed ID: 31987040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of sphingolipid metabolism as a putative mechanism underlying LPS-induced BBB disruption.
    Vutukuri R; Brunkhorst R; Kestner RI; Hansen L; Bouzas NF; Pfeilschifter J; Devraj K; Pfeilschifter W
    J Neurochem; 2018 Jan; 144(2):172-185. PubMed ID: 29023711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Site-specific opening of the blood-brain barrier by extracellular histones.
    Villalba N; Baby S; Cha BJ; Yuan SY
    J Neuroinflammation; 2020 Sep; 17(1):281. PubMed ID: 32962721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A functional in vitro model of rat blood-brain barrier for molecular analysis of efflux transporters.
    Perrière N; Yousif S; Cazaubon S; Chaverot N; Bourasset F; Cisternino S; Declèves X; Hori S; Terasaki T; Deli M; Scherrmann JM; Temsamani J; Roux F; Couraud PO
    Brain Res; 2007 May; 1150():1-13. PubMed ID: 17434463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of lipopolysaccharide on leptin transport across the blood-brain barrier.
    Nonaka N; Hileman SM; Shioda S; Vo TQ; Banks WA
    Brain Res; 2004 Jul; 1016(1):58-65. PubMed ID: 15234252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditions.
    Ramirez SH; Haskó J; Skuba A; Fan S; Dykstra H; McCormick R; Reichenbach N; Krizbai I; Mahadevan A; Zhang M; Tuma R; Son YJ; Persidsky Y
    J Neurosci; 2012 Mar; 32(12):4004-16. PubMed ID: 22442067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactate reduces liver and pancreatic injury in Toll-like receptor- and inflammasome-mediated inflammation via GPR81-mediated suppression of innate immunity.
    Hoque R; Farooq A; Ghani A; Gorelick F; Mehal WZ
    Gastroenterology; 2014 Jun; 146(7):1763-74. PubMed ID: 24657625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome-proliferator-activated receptor-alpha activation protects brain capillary endothelial cells from oxygen-glucose deprivation-induced hyperpermeability in the blood-brain barrier.
    Mysiorek C; Culot M; Dehouck L; Derudas B; Staels B; Bordet R; Cecchelli R; Fenart L; Berezowski V
    Curr Neurovasc Res; 2009 Aug; 6(3):181-93. PubMed ID: 19534718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monomeric α-synuclein induces blood-brain barrier dysfunction through activated brain pericytes releasing inflammatory mediators in vitro.
    Dohgu S; Takata F; Matsumoto J; Kimura I; Yamauchi A; Kataoka Y
    Microvasc Res; 2019 Jul; 124():61-66. PubMed ID: 30885616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipopolysaccharide-induced blood brain barrier permeability is enhanced by alpha-synuclein expression.
    Jangula A; Murphy EJ
    Neurosci Lett; 2013 Sep; 551():23-7. PubMed ID: 23876253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(ADP-ribose) polymerase-1 inhibition in brain endothelium protects the blood-brain barrier under physiologic and neuroinflammatory conditions.
    Rom S; Zuluaga-Ramirez V; Dykstra H; Reichenbach NL; Ramirez SH; Persidsky Y
    J Cereb Blood Flow Metab; 2015 Jan; 35(1):28-36. PubMed ID: 25248836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase C-delta inhibition protects blood-brain barrier from sepsis-induced vascular damage.
    Tang Y; Soroush F; Sun S; Liverani E; Langston JC; Yang Q; Kilpatrick LE; Kiani MF
    J Neuroinflammation; 2018 Nov; 15(1):309. PubMed ID: 30400800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.